Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTCQB:SNTI) announced today that it will make two presentations on its gene regulation technology (SNS01-T) for blood-borne cancer care at the 55th American Society of Hematology (ASH) Annual Meeting and Exposition to be held from December 7-10th in New Orleans, Louisiana. The abstracts are available on the ASH website at www.hematology.org.
Help employers find you! Check out all the jobs and post your resume.
